Irena Webster

Irena joined Forma in 2020 with over 17 years of experience in drug development across the biotech and pharmaceutical industries. She is the vice president, head of development operations, overseeing clinical operations and biometrics and leading the planning and oversight of operational strategy and trial execution. Prior to Forma, Irena served as director, head of early clinical development operations at Sage Therapeutics, where she led an operational team that worked closely with the lead optimization, translational, and medical teams focused on experimental medicine, including signal-finding trials and biomarker development in neurological disorders and rare disease. Prior to Sage, she worked at Alkermes where she was the clinical operations lead on multiple clinical programs across depression, schizophrenia, addiction and reward disorders. Throughout her career, Irena has led global trial execution in cardiovascular disorders, oncology, rare diseases and central nervous system disorders, contributing to multiple NDAs and sNDAs. Irena earned a Master of Public Health degree from New York Medical College.